FDA issued a Warning Letter to Apotex Pharmachem India Pvt Ltd. on 6/16/2014 for a previous inspection.
483 Apotex Pharmachem India Jun 2016

483 Apotex Pharmachem India Jun 2016

Virgilio Pacio FDA, Tsedenia Woldehanna FDA$119.00 - Available Now

FDA investigators audited the Apotex Pharmachem India - Bangalore, India facility and issued inspectional observations (via FDA 483) on 03 Jun 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 03 Jun 2016
  • Location: Bangalore, India
  • FEI: 3005466325
Add To Cart